LENSAR INC
LNSR · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $6.32
- Today’s Low
- $6.20
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $6.38
- Previous Close
- $6.22
- Volume
- 43.75K
- Market Cap
- $76.41M
- P/E Ratio
- 2.19X
- EPS
- $2.08
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 2800 DISCOVERY DRIVE, ORLANDO, FL, UNITED STATES, 32826
- Country
- US
- Listing Date
- 2020-09-21
- Fiscal Year End
- December
- Shares Outstanding
- 12.28M
- CIK
- 0001320350
- Website
- www.lensar.com
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.
Financial Metrics
Revenue
2026-06-30
$16.49M
2026-03-31
$13.42M
2025-12-31
$16.02M
2025-09-30
$14.31M
Operating Expenses
2026-06-30
$7.64M
2026-03-31
$4.14M
2025-12-31
$11.85M
2025-09-30
$13.38M
Net Income
2026-06-30
$3.53M
2026-03-31
$36.33M
2025-12-31
-$1.45M
2025-09-30
-$3.71M
Net Profit Margin
2026-06-30
21.43%
2026-03-31
270.56%
2025-12-31
-9.09%
2025-09-30
-25.93%
Earnings Per Share
2026-06-30
$0.10
2026-03-31
$-0.19
2025-12-31
$-0.10
2025-09-30
$-0.11
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$1.83M
2026-03-31
$37.46M
2025-12-31
-$284K
2025-09-30
-$2.55M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $16.49M | $13.42M | $16.02M | $14.31M |
| Operating Expenses | $7.64M | $4.14M | $11.85M | $13.38M |
| Net Income | $3.53M | $36.33M | -$1.45M | -$3.71M |
| Net Profit Margin | 21.43% | 270.56% | -9.09% | -25.93% |
| Earnings Per Share | $0.10 | $-0.19 | $-0.10 | $-0.11 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $1.83M | $37.46M | -$284K | -$2.55M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.